ABSTRACT Bronchoalveolar lavage fluid from 43 patients with biopsy proved sarcoidosis and 10 control subjects were assayed for fibronectin and collagenase activity. 
Pulmonary sarcoidosis is often a self limiting disease, with spontaneous resolution occurring in about 80% of patients. In the remaining 20% parenchymal injury and fibrosis is frequently observed. This progression to fibrosis, with loss of lung function, represents the most serious manifestation of the disease. Current concepts of the pathogenesis of pulmonary fibrosis suggest that two events are required for the development of fibrosis-(a) a derangement of the normal alveolar architecture and (b) an increase in the number and level of activation of lung fibroblasts.' Studies of patients with idiopathic pulmonary fibrosis suggest that considerable damage to alveolar structure is due to the release of hydrolytic enzymes, most notably collagenase, by neutrophils, which are present in the lungs of these patients.2 Alveolar macrophages from patients with idiopathic pulmonary fibrosis produce increased quantities of fibronectin and growth factors that stimulate the proliferation and activation of fibroblasts.34 Alveolar macrophages from patients that the mechanism of recruitment and activation of fibroblasts is similar in the two diseases. 34 The events that cause alveolar derangement in sarcoidosis are unclear. There is conflicting evidence on whether collagenase is present in lavage fluid from patients with sarcoidosis.56 Some workers suggest that alveolar damage is caused by the influx of inflammatory cells and granuloma formation,7 whereas others suggest that neutrophils may have an important role in the fibrotic process in sarcoidosis."9 The present study set out to assess the levels of two putative fibrogenic markers-fibronectin and collagenase-in the lavage fluids from a group of patients with sarcoidosis and to compare these levels with physiological, radiological, immunological, and biochemical indices of disease severity or activity.
Methods

STUDY POPULATION
Forty three patients with sarcoidosis (32 of them male), mean age 35-3 (range 20-68) years in 0-05 M tris containing 0 005 M CaCI2 and 0-2 M NaCl (pH 7-5) was incubated with 100 p1 of concentrated lavage fluid at 35°C for 90 minutes. p-Aminophenylmercuric acetate (APMA) at a final concentration of 1 mmol/l was included to activate latent enzyme.'2 The reaction was terminated by the addition of 100 mM EDTA and 100 pg of unlabelled collagen.
Incubation was continued for a further 30 minutes to allow complete denaturation of the cleaved fragments. Four hundred microlitres of dioxane: methanol:water (4:1:5 volume) was then added to precipitate undigested collagen and the samples were centrifuged at 2500 g for 60 minutes. The supernatant, containing digested collagen fragments, was counted on a Beckman Rack Beta scintillation counter (Model 1217-001) after the addition of 10 ml of scintillation fluid (4 g/l PPO in toluene:triton X, 2:1 v/v). Samples were assayed in duplicate and a control, to which EDTA and unlabelled collagen were added before incubation, was included for each sample. The difference in counts between test and control samples was used to calculate units ofcollagenase activity as micrograms ofcollagen degraded per minute per millilitre of lavage fluid. The sensitivity limit of the assay was 0 35 units/ml.
Fibronectin was measured by an enzyme linked immunosorbent assay (ELISA).'3 Purified human fibronectin and antibody to human fibronectin was obtained from Boehringer Mannheim GmbH (Mannheim, West Germany). Protein was determined by a modification of the Lowry method. 14 Angiotensin converting enzyme (ACE) activity was measured in x 20 concentrates of lavage fluid. '5 Collagenase andfibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis
NORMALISATION OF BRONCHOALVEOLAR LAVAGE FLUID PROTEINS
No satisfactory reference component for normalisation of lavage fluid proteins is currently available. Albumin, a useful reference in normal subjects, is unsatisfactory in disease states where alveolitis or capillary leakage occur.'6 Expression of protein concentrations with respect to volume of fluid recovered also presents problems in patients with sarcoidosis as variation has been noted both between control and sarcoidosis groups and between subgroups of patients divided according to disease activity and severity. '7"8 To minimise this problem, urea, a small molecular weight compound that diffuses freely across the capillary endothelium, was chosen as a reference component. Urea concentrations in the bronchoalveolar lavage fluid of controls and patients with sarcoidosis were similar (control: 3 1, range 1-4-9 1 gg ml; sarcoid: 3.3, range 0-9-12 5 jg/ml). Within the sarcoidosis group no association was noted between urea concentrations in bronchoalveolar lavage fluid and disease activity or severity. Thus the problems associated with albumin and volume in normalising bronchoalveolar lavage fluid protein concentrations were largely overcome by using bronchoalveolar lavage fluid urea as reference. Problems associated with variation in bronchoalveolar lavage fluid urea owing to the dwell time of infused saline, however, still remain. ' 
Results
The collagenase assay was shown to measure true mammalian collagenase activity on analysis of the reaction products by SDS polyacrylamide gel electrophoresis (fig 1) . The electrophoretic profile of the cleaved collagen was typical of that observed for collagenase digestion of type I collagen. 23 Preliminary experiments indicated that APMA was slightly more effective than trypsin in activating latent collagenase in lavage fluid (APMA activation 1-8 (SD 0-67) units/ml; trypsin activation 1-26 (0.5) units/ml, n = 4), so APMA activation was used throughout the study. Inclusion of PMSF in the lavage samples and APMA in the reaction mixture protected against interference by serine proteases.
BRONCHOALVEOLAR LAVAGE FLUID
The detection limit for the ELISA was 5 ng/ml. fluid of all subjects (fig 2a) , with a median concentration in the control group of 0 07 pg/pg urea, range 001-0 12. Fibronectin concentrations were raised in the sarcoidosis group (median 0-18, range 0-01-084 pg/pg urea; p < 0-01), 20 of the 43 patients having concentrations greater than 0-20 pg/pg urea (mean control level plus 2 SD). Collagenase activity was absent in the lavage fluid from the control subjects, but present in 16 of the patients (fig 2b) . There was no association between current smoking habit and either collagenase activity or fibronectin concentration.
There was a positive correlation between fibronectin levels and both lavage ACE and protein (figs 3a and 3b) in patients with sarcoidosis but not in the control group. There was no similar association between bronchoalveolar lavage fluid collagenase levels and ACE or protein. stimulation of normal alveolar macrophages fails to elicit an increase in fibronectin production,3 suggesting that a specific "in vivo" stimulus or a particular subset of "primed" alveolar macrophages may be responsible O'Connor, Odium, Van Breda, Power, FitzGerald for the observed increase in fibronectin. Increased fibronectin concentrations in the bronchoalveolar lavage fluid was not related to functional or radiographic indices of disease severity and did not identify patients subsequently requiring treatment. Thus, despite an association between bronchoalveolar lavage fluid fibronectin and active alveolitis, no evidence of a link between bronchoalveolar lavage fluid fibronectin and subsequent fibrosis was observed.
Latent collagenase activity was detected in lavage fluid from 16 of the 43 patients studied. Gadek et al failed to detect collagenase, either active or latent, in bronchoalveolar lavage fluid from nine patients with sarcoidosis. By contrast, Cordier and coworkers6 detected collagenolytic activity in three patients with sarcoidosis. The key to these discrepancies may lie in the profiles of the patients. The group studied by Gadek et al had normal lung volumes and diffusing capacities. Pulmonary function data are not given by Cordier et al, but lung biopsy showed evidence of intense fibrosis in two of the three patients. In our study most (56%) patients with bronchoalveolar lavage fluid collagenase had diffusing capacities of less than 80% predicted and five had radiographic evidence of fibrosis. In addition, a high proportion of these patients had been diagnosed over two years previously, half had received previous corticosteroid treatment, and 62% required treatment after lavage. These results suggest an association between bronchoalveolar lavage fluid collagenase activity and prolonged, progressive disease in sarcoidosis.
Collagenase activity has also been detected in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and the adult respiratory distress syndrome, diseases in which interstitial fibrosis occurs more rapidly than in sarcoidosis.228 It is suggested that digestion of interstitial collagen by collagenase in the lower respiratory tract contributes to the derangement of alveolar structures and the disordered pattern of collagen deposition seen in these diseases. Alveolar derangement and collagen accumulation also occurs in some patients with sarcoidosis, though usually over a prolonged period. Our results suggest that the role of collagenase in the development ofinterstitial fibrosis may be similar in all three diseases.
The source of bronchoalveolar lavage fluid collagenase in patients with sarcoidosis remains unclear. Three cells present in the lower respiratory tract are capable of producing collagenase-the macrophage, the fibroblast, and the neutrophil. In idiopathic pulmonary fibrosis lavage fluid collagenase is associated with an increase in neutrophils. Increased numbers of neutrophils are also observed in the adult respiratory distress syndrome, though Christner et aft indicate that production of collagen-Collagenase andfibronectin in bronchoalveolar lavagefluid in patients with sarcoidosis ase by fibroblasts may also contribute to the increased bronchoalveolar lavage fluid collagenase seen in this disease. Neutrophils are rarely increased in lavage fluid from patients with sarcoidosis. An increased proportion of neutrophils in patients with advanced disease and fibrosis has, however, been reported.89 In our study only three of the 16 patients with collagenase in the bronchoalveolar lavage fluid had increased neutrophil counts (>2%) and there was no correlation between the numbers of neutrophils and the collagenase activity. Activated alveolar macrophages also produce collagenase29; yet there was no correlation between bronchoalveolar lavage fluid collagenase activity and the number of alveolar macrophages recovered on lavage. This, however, does not rule out the alveolar macrophage as source of bronchoalveolar lavage fluid collagenase as collagenase production by monocytic cells has been shown to vary with maturation and activation state.03' Further studies using antibodies to alveolar macrophage, fibroblast, and neutrophil collagenase are needed to positively identify the cellular source of bronchoalveolar lavage fluid collagenase in patients with sarcoidosis.
The collagenase detected in lavage fluids from patients with sarcoidosis was present in a latent form and was measurable only after activation with either APMA or trypsin. Activation of collagenase by organomercuricals, such as APMA, has led some investigators to suggest that latent collagenase is produced as an enzyme-inhibitor complex that can be dissociated by a sulphydryl exchange mechanism.32 More recent studies indicate that latent collagenase secreted by both fibroblasts and neutrophils is in a zymogen or proenzyme form,3334 which can be autoactivated after perturbation of its tertiary structure by APMA. 35 Preliminary studies in this laboratory indicate that latent collagenase from human alveolar macrophages can also be activated by APMA. Thus the latent collagenase may be in a proenzyme form. Alveolar macrophages also, however, produce a collagenase inhibitor identical to tissue metalloproteinase inhibitor,29 and tissue metalloproteinase inhibitor has been detected in lavage fluid from control subjects.6 Another collagenase inhibitor, X2M, is also present in lavage fluid.37 Whether complexes of collagenase and these inhibitors can be dissociated by APMA is a matter ofcontroversy38; thus the possibility exists that the "latent" collagenase measured in lavage fluid is a collagenase-inhibitor complex resulting from 'in vivo" activation and inhibition.
In summary, assay oflavage fluid from patients with sarcoidosis for fibronectin and collagenase has indicated an association between active disease and raised fibronectin concentrations, but no association between fibronectin concentration and functional impairment or further deterioration was observed. A high proportion of patients with progressive, prolonged disease had collagenase activity in their lower respiratory tracts, suggesting that collagenase may have a role in the development of fibrosis in sarcoidosis. The cellular source of this collagenase is unclear. 
